Medical Developments International Limited (AU:MVP) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Medical Developments International Limited reported a significant improvement in financial performance for FY24, with a $6.6 million increase in underlying EBIT and a $10.2 million surge in free cashflow. Despite a net loss, the company saw Penthrox market growth, especially in Australian hospitals and Europe, and anticipates positive operating cashflow by FY25 end. The company also completed a $10 million capital raise to fuel further growth.
For further insights into AU:MVP stock, check out TipRanks’ Stock Analysis page.